通过DERA催化的化学酶获取核基替代候选性他类药物前体
Romina Fernández Varela1, Eman Abdelraheem2, Lautaro Giaimo1
1Laboratorio de Biotransformaciones y Química de Ácidos Nucleicos, Universidad Nacional de Quilmes, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Roque S. Peña 352, Bernal B1876BXD, Argentina.
Biomolecules
|February 27, 2026
概括
研究人员开发了一种新的化学酶方法,使用二-脱氧-5-酸盐阿尔多酶 (DERA) 来制造新型他类药物前体. 这种方法成功地合成了核基替代的乳醇,扩大了DERA.
科学领域:
- 生物催化剂和合成化学
- 酶工程与应用 酶工程与应用
- 药用化学和药物发现
背景情况:
- 阿尔多酶是刻板选择性碳-碳键形成的关键生物催化剂,对于合成制药中间体至关重要.
- 2-脱氧-5-酸阿尔多酶 (DERA) 对于生产他类药物的侧链特别有价值.
- 对于他类药物模拟合成的现有方法,其范围和前体多样性可能受到限制.
研究的目的:
- 开发一种新的化学酶策略,用于合成核基替代乳醇.
- 探索使用基功能化核基作为DERA的基材.
- 为具有多样结构的新型他类药物产生潜在的前体.
主要方法:
- 作为生物催化剂,使用了*Pectobacterium atrosepticum* DERA (PaDERA C49M) 的C49M变种.
- 采用了由PADERA C49M催化的顺序阿尔多尔添加剂.
- 引入了非天然的电友基质:基功能化核基.
主要成果:
- 成功合成了含有核基的乳产品.
- 首次证实了DERA在阿尔多尔反应中接受核基衍生的化物.
- 证明了结构新的他类药物侧链前体的形成.
结论:
- 新的化学酶方法扩大了DERA的合成效用.
- 这一战略通过新型他类药物前体,提供了新类生物活性化合物的获取.
- 这些发现为设计下一代他类药物类似物和其他复杂分子开辟了道路.
相关概念视频
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.9K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.9K
Synthesis of α-Substituted Carbonyl Compounds: The Stork Enamine Reaction
4.2K
α-Substituted ketones or aldehydes can be synthesized from enamines by the Stork enamine reaction, named after its pioneer Gilbert Stork. Enamines are useful synthetic intermediates where the lone pair on nitrogen is in conjugation with the C=C bond. They resemble enolate ions, as the resonance forms of both species have a nucleophilic α carbon.
4.2K
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
4.3K
Malonic ester synthesis is a method to obtain α substituted carboxylic acids from ꞵ-diesters such as diethyl malonate and alkyl halides.
4.3K
Biosynthesis of Nucleic Acids
1.3K
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.3K
Alkylation of β-Ketoester Enolates: Acetoacetic Ester Synthesis
4.7K
Acetoacetic ester synthesis is a method to obtain ketones from alkyl halides and β-keto esters. The reaction occurs in the presence of an alkoxide base that abstracts the acidic proton of the β-keto esters. The step results in an enolate ion which is doubly stabilized. The enolate then reacts with an alkyl halide via the SN2 process to produce an alkylated ester intermediate with a new C–C bond. The hydrolysis of the intermediate, followed by acidification, results in an...
4.7K
Nucleophilic Acyl Substitution of Carboxylic Acid Derivatives
5.1K
Nucleophilic acyl substitution is an important class of substitution reactions involving a nucleophile and an acyl compound, such as carboxylic acids and their derivatives. In these reactions, the leaving group attached to the acyl group is substituted by a nucleophile. The general mechanism proceeds via two steps.
5.1K


